Related Experiment Video
Updated: Jul 15, 2025

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
BMSC-derived exosomal miR-148b-3p attenuates OGD/R-induced HMC3 cell activation by targeting DLL4 and Notch1
Fang Yi1, Hui Xiao2, Mingyu Song3
1Department of Geriatric Neurology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, PR China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan 410008, PR China.
Abstract:
Bone mesenchymal stem cell (BMSC)-derived exosome (BMSC-Exo) could be a treatment method for ischemic injury. In ischemic cerebrovascular disease (IC), microglia is pivotal in neuronal damage and remodeling. This study explores the mechanisms of BMSC-Exo miR-148b-3p in regulating oxygen-glucose deprivation/reoxygenation (OGD/R)-induced human microglial clone 3 (HMC3) cell activation. Transmission electron microscopy (TEM) and qNano were used to assess BMSC-Exo features. The functions of BMSC-Exo miR-148 b-3p in OGD/R-induced HMC3 cell activation were explored via MTT assay, flow cytometry, scratch, transwell, and enzyme-linked immunosorbent assay (ELISA) assays. A dual-luciferase reporter assay was performed to determine the relationship between miR-148b-3p and Delta-like ligand 4(DDL4) or neurogenic locus notch homolog protein 1 (Notch1). OGD/R decreased miR-148b-3p expression in HMC3 cells. After BMSC-Exo treatment, miR-148b-3p expression was upregulated, cell viability and migration were inhibited, cell cycles remained in the G0/G1 phase, and proinflammatory cytokines were decreased in OGD/R-induced HMC3 cells. More importantly, BMSC-Exo miR-148b-3p could further strengthen BMSC-Exo effects. DDL4 and Notch1 are direct targets of miR-148b-3p, respectively. Moreover, the knockdown of DLL4 or Notch1 could inhibit OGD/R-induced HMC3 cell activation. BMSC-Exo miR-148b-3p inhibited OGD/R-induced HMC3 cell activation via inhibiting DLL4 and Notch1 expression, which provided a new strategy for treating cerebral ischemia.
Insights
Bone mesenchymal stem cell-derived exosomes (BMSC-Exo) carrying miR-148b-3p can treat ischemic injury by inhibiting microglial activation via the DLL4/Notch1 pathway.
Area of Science:
- Biomedical Science
- Cell Biology
- Neuroscience
Background:
- Ischemic cerebrovascular disease (IC) involves microglial activation, contributing to neuronal damage.
- Bone mesenchymal stem cell (BMSC)-derived exosomes (BMSC-Exo) show potential therapeutic effects for ischemic injuries.
- Understanding the regulatory mechanisms of BMSC-Exo in microglial activation is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the role of BMSC-Exo miR-148b-3p in regulating oxygen-glucose deprivation/reoxygenation (OGD/R)-induced microglial activation.
- To elucidate the underlying molecular mechanisms involving Delta-like ligand 4 (DLL4) and neurogenic locus notch homolog protein 1 (Notch1).
Main Methods:
- Characterization of BMSC-Exo using Transmission Electron Microscopy (TEM) and qNano.
- Assessment of HMC3 cell activation via MTT, flow cytometry, scratch, transwell, and ELISA assays.
- Dual-luciferase reporter assay to confirm the targeting relationship between miR-148b-3p and DLL4/Notch1.
Main Results:
- OGD/R reduced miR-148b-3p expression in HMC3 cells; BMSC-Exo treatment upregulated miR-148b-3p.
- BMSC-Exo inhibited OGD/R-induced HMC3 cell viability, migration, and pro-inflammatory cytokine release, while promoting G0/G1 phase arrest.
- miR-148b-3p directly targets DLL4 and Notch1, and its knockdown or inhibition of DLL4/Notch1 attenuated OGD/R-induced microglial activation.
Conclusions:
- BMSC-Exo miR-148b-3p effectively inhibits OGD/R-induced microglial activation by targeting DLL4 and Notch1.
- This pathway presents a novel therapeutic strategy for treating cerebral ischemia.
- BMSC-Exo miR-148b-3p holds significant promise as a treatment for ischemic cerebrovascular disease.
More Related Videos
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Related Concept Videos
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Hedgehog Signaling Pathway